Camp4 Therapeutics Corp (CAMP) Executive Compensation
Camp4 Therapeutics Corp (CAMP) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: CAMP
CIK: 1736730
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2023 12:00:00 AM
Lead Engagement PartnerVictoria Forward
Audit LocationBoston, Massachusetts, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-09-28 | 2026-09-28 | 8-K | 0001628280-26-063740 | View SEC Doc Filr Page |
| 4 | 2026-09-02 | 2026-08-31 | FORM 4 | 0001628280-26-060234 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-08-31 | — | SCHEDULE 13D/A Filing | 0001753037-26-000007 | View SEC Doc Filr Page |
| 4 | 2026-08-31 | 2026-08-27 | 4 Filing | 0001598549-26-000011 | View SEC Doc Filr Page |
| 4 | 2026-08-26 | 2026-08-24 | 4 Filing | 0001598549-26-000009 | View SEC Doc Filr Page |
| 4 | 2026-08-21 | 2026-08-19 | 4 Filing | 0001598549-26-000007 | View SEC Doc Filr Page |
| 4 | 2026-08-19 | 2026-08-19 | FORM 4 | 0001628280-26-058107 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-08-19 | — | SCHEDULE 13D/A Filing | 0001193125-26-357272 | View SEC Doc Filr Page |
| 144 | 2026-08-19 | — | 144 Filing | 0001974494-26-000263 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001172661-26-003419 | View SEC Doc Filr Page |
| 10-Q | 2026-08-13 | 2026-06-30 | 10-Q | 0001628280-26-056760 | View SEC Doc Filr Page |
| 8-K | 2026-08-13 | 2026-08-13 | 8-K | 0001628280-26-056758 | View SEC Doc Filr Page |
| EFFECT | 2026-08-12 | — | EFFECT Filing | 9999999995-26-002650 | View SEC Doc Filr Page |
| 424B3 | 2026-08-12 | — | 424B3 | 0001628280-26-056325 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-10 | — | SCHEDULE 13G Filing | 0001493152-26-036926 | View SEC Doc Filr Page |
| S-3 | 2026-08-06 | — | S-3 | 0001628280-26-054389 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-08-05 | — | SCHEDULE 13D/A Filing | 0001753037-26-000003 | View SEC Doc Filr Page |
| 4 | 2026-08-05 | 2026-08-03 | 4 Filing | 0001231919-26-000829 | View SEC Doc Filr Page |
| 4 | 2026-08-05 | 2026-08-03 | 4 Filing | 0001598549-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-08-05 | 2026-08-03 | FORM 4 | 0001628280-26-053513 | View SEC Doc Filr Page |
| 4 | 2026-08-05 | 2026-08-03 | FORM 4 | 0001628280-26-053512 | View SEC Doc Filr Page |
| 4 | 2026-08-05 | 2026-08-03 | FORM 4 | 0001628280-26-053511 | View SEC Doc Filr Page |
| 4 | 2026-08-05 | 2026-08-03 | FORM 4 | 0001628280-26-053505 | View SEC Doc Filr Page |
| 8-K | 2026-08-04 | 2026-08-03 | 8-K | 0001628280-26-052150 | View SEC Doc Filr Page |
| 8-K | 2026-07-27 | 2026-07-27 | 8-K | 0001628280-26-049661 | View SEC Doc Filr Page |